Copertina

Computational Insights into the Structural Basis for Reduced Hepatotoxicity of Novel Nonopioid Analgesics

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Claire Coderch, Hernan A. Bazán, Nicolas G. Bazan, Bhattacharjee Surjyadipta, Julio Alvarez‐Builla, Beatriz de Pascual‐Teresa
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Structural Basis of Conformational Dynamics in the PROTAC‐Induced Protein Degradation
di: Hongtao Zhao
Pubblicazione: (2024)

The Spanish Society of Medicinal Chemistry: Promoting Pharmaceutical R&D in Spain since 1977
di: José‐Manuel Bartolomé‐Nebreda, et al.
Pubblicazione: (2024)

Structure‐Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off‐Target Effects
di: Daniela Passeri, et al.
Pubblicazione: (2026)

Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
di: Gints Kalnins, et al.
Pubblicazione: (2024)

Structure‐ and Ligand‐Based Discovery of Novel 3‐Chymotrypsin‐Like Protease Nonpeptidomimetic Hits
di: Sabrina Silva‐Mendonça, et al.
Pubblicazione: (2026)

Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic
di: Maria Pia Lenza, et al.
Pubblicazione: (2025)

Sertraline as a Scaffold for Antitrypanosoma Cruzi Drug Development: Design of Novel Derivatives and Computational Target Screening
di: Ali S. Mijoba, et al.
Pubblicazione: (2025)

Front Cover: Structure‐ and Ligand‐Based Discovery of Novel 3‐Chymotrypsin‐Like Protease Nonpeptidomimetic Hits (ChemMedChem 7/2026)
di: Sabrina Silva‐Mendonça, et al.
Pubblicazione: (2026)

Discovery of Novel Pyrido[2,3‐b]Pyrazine Human Cytomegalovirus Polymerase Inhibitors with Broad Spectrum Antiherpetic Activity and Reduced hERG Inhibition
di: Bing Bai, et al.
Pubblicazione: (2024)

Emerging Trends in Quinoxaline‐Based Analogs as Protein Kinase Inhibitors: Structural Developments and SAR Insights
di: Shivani, et al.
Pubblicazione: (2024)

Structure‐Based Virtual Screening and Biological Characterization of Novel BACE‐1 and Amyloid‐β Aggregation Inhibitors
di: Ankita Sharma, et al.
Pubblicazione: (2024)

Novel Vancomycin‐β‐Lactam Hybrids: Structure–Activity Relationships and Therapeutic Potential Against VISA and VRE
di: Taopeng Chang, et al.
Pubblicazione: (2026)

New Binding Sites for JAK2 Inhibition in Myeloproliferative Neoplasms: Structural Insights, Therapeutic Potential, and Future Directions
di: Gang Zhao, et al.
Pubblicazione: (2026)

Discovery of [1,2,4]triazolo[1,5‐ a ]pyrimidine‐Imatinib Hybrids With Selective Cytotoxic Activity: A Mechanistically Divergent Series From Direct BCR‐ABL1 Inhibition
di: Stefany Castro Bazan Moura, et al.
Pubblicazione: (2026)

Identification of Novel and Selective GPR39 Receptor Antagonists for the Treatment of Acute Myocardial Ischemia
di: Agostino Cianciulli, et al.
Pubblicazione: (2025)

Exploration of the Tertiary Amide Chemical Space of Dolastatin 15 Analogs Reveals New Insights into the Structure–Anticancer Activity Relationship
di: Dayana Alonso, et al.
Pubblicazione: (2025)

Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis
di: Igor Resendes Barbosa, et al.
Pubblicazione: (2025)

A Novel Triose Phosphate Isomerase Inhibitor With Dual Trypanosomicidal Activity was Identified Using Artificial Intelligence‐Based Virtual Screening
di: Elena Aguilera, et al.
Pubblicazione: (2026)

Front Cover: Structure‐Based Drug Design of Novel Heterocyclic Scaffolds as TgCDPK1 Inhibitors (ChemMedChem 18/2025)
di: Anoopjit Singh Kooner, et al.
Pubblicazione: (2025)

Front Cover: Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis (ChemMedChem 9/2025)
di: Igor Resendes Barbosa, et al.
Pubblicazione: (2025)

Synthesis and Structure–Activity Relationship Studies of Novel Oxazolyl‐ and Thiazolyl‐Indoles and their Intermediates as Selective Antiproliferative Agents Against HL‐60 Leukemia and C6 Glioma Cell Lines
di: Patrik Pollák, et al.
Pubblicazione: (2025)

Development of Novel Anticancer Pyrazolopyrimidinones Targeting Glioblastoma
di: Kate Byrne, et al.
Pubblicazione: (2025)

Developing Dynamic Structure‐Based Pharmacophore and ML‐Trained QSAR Models for the Discovery of Novel Resistance‐Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis
di: Ehsan Sayyah, et al.
Pubblicazione: (2024)

Anti‐Sporothrix Activity of Novel Copper‐Itraconazole Complexes
di: José Aleixo de Azevedo‐França, et al.
Pubblicazione: (2024)

Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
di: Sadık Hüseyin Cemali, et al.
Pubblicazione: (2025)

Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
di: Isabelle Lyothier, et al.
Pubblicazione: (2025)

Investigation of Novel Isatinylhydantoin Derivatives as Potential Anti‐Kinetoplastid Agents
di: Keamogetswe Sechoaro, et al.
Pubblicazione: (2024)

Synthesis of Novel Fluorinated Febrifugine Analogs and Evaluation of Their Antifungal Activity
di: Fahad Alkhathami, et al.
Pubblicazione: (2026)

Investigating the Ligand‐Binding Properties of N‐arylbenzimidazoles as Novel Elastase Inhibitors
di: Giovanna Pitasi, et al.
Pubblicazione: (2025)

The IMS Library: from IN‐Stock to Virtual
di: Teodora Djikic‐Stojsic, et al.
Pubblicazione: (2024)

Cover Feature: The IMS Library: from IN‐Stock to Virtual (ChemMedChem 20/2024)
di: Teodora Djikic‐Stojsic, et al.
Pubblicazione: (2024)

N,N‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation
di: Dattatraya A. Babar, et al.
Pubblicazione: (2024)

An Interdisciplinary Approach Provides Insights into the Pronounced Selectivity of Compound 42 for DPP9
di: Olivier Beyens, et al.
Pubblicazione: (2024)

Key Insights on the Classification and Theranostic Applications of Magnetic Resonance Imaging Contrast Agents
di: Jasleen Kaur, et al.
Pubblicazione: (2024)

Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy
di: Lixiao Zhang, et al.
Pubblicazione: (2025)

Design and Synthesis of Novel β‐Carboline‐Bisindole Hybrids as Potential Anticancer Agents
di: Nguyen Thi Thanh Huyen, et al.
Pubblicazione: (2024)

Nature‐inspired Novel Quaternary Ammonium Compounds: Synthesis, Antibacterial and Antibiofilm Activity
di: Liubov Muzychka, et al.
Pubblicazione: (2024)

Diversity Oriented Synthesis of Novel Xanthones Reveal Potent Doxorubicin‐Inspired Analogs
di: Jonas W. Meringdal, et al.
Pubblicazione: (2024)

Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4
di: Raghuvir H. Gaonkar, et al.
Pubblicazione: (2025)

Insights into Molecular Interactions and Biological Effect of Natural Stilbenoids at the TRPA1 Ion Channel
di: Atefeh Saadabadi, et al.
Pubblicazione: (2024)